Ortikos (budesonide), the First and Only Once-Daily Dose for Treatment of Mild to Moderate Crohn ’s Disease, Now Available in the U.S.

Parsippany, NJ– July 29, 2020– Ferring Pharmaceuticals Inc. today announced the launch of Ortikos (budesonide) in the United States, which is approved as the only once-daily treatment of mild to moderate active Crohn’s disease...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news